Evidence map›Paper›PMID 36656356›Full record

Observational studyJournal of neurology2023

MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms.

Serena Capelli, Anna Caroli, Antonino Barletta, Alberto Arrigoni, Angela Napolitano, Giulio Pezzetti, Luca Giovanni Longhi, Rosalia Zangari, Ferdinando Luca Lorini, Maria Sessa and 2 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Olfactory Dysfunction and Cognitive Decline: Are They Related?Current allergy and asthma reports · 2025
    Review
  5. Review
  6. Review
  7. Changes in olfactory bulb volume and olfactory sulcus depth in COVID-19 infection: an autopsy study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Long-term effects of SARS-CoV-2 infection in patients with and without chemosensory disorders at disease onset: a psychophysical and magnetic resonance imaging exploratory study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Serena CapelliBioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, BG, Italy.ORCID http://orcid.org/0000-0002-8450-3806
Anna CaroliBioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, BG, Italy.ORCID http://orcid.org/0000-0002-4130-4663
Antonino BarlettaDepartment of Neuroradiology, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127, Bergamo, Italy.ORCID http://orcid.org/0000-0002-7234-9899
Alberto ArrigoniBioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica, BG, Italy.ORCID http://orcid.org/0000-0002-1914-6582
Angela NapolitanoDepartment of Neuroradiology, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127, Bergamo, Italy.ORCID http://orcid.org/0000-0001-8423-4485
Giulio PezzettiDepartment of Neuroradiology, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127, Bergamo, Italy.
Luca Giovanni LonghiNeurosurgical Intensive Care Unit, Department of Anesthesia and Critical Care Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy.
Rosalia ZangariFROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.ORCID http://orcid.org/0000-0002-4425-7866
Ferdinando Luca LoriniDepartment of Emergency and Critical Care Area, ASST Papa Giovanni XXIII, Bergamo, Italy.ORCID http://orcid.org/0000-0002-2711-3377
Maria SessaDepartment of Neurology, ASST Papa Giovanni XXIII, 24127, Bergamo, Italy.ORCID http://orcid.org/0000-0002-9589-0290
Andrea RemuzziDepartment of Management, Information and Production Engineering, University of Bergamo, Dalmine, BG, Italy.ORCID http://orcid.org/0000-0002-4301-8927
Simonetta GereviniDepartment of Neuroradiology, ASST Papa Giovanni XXIII, Piazza OMS 1, 24127, Bergamo, Italy. sgerevini@asst-pg23.it.ORCID http://orcid.org/0000-0002-2374-194X
Ospedale Papa Giovanni XXIII · ITMario Negri Institute for Pharmacological Research · ITUniversity of Bergamo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveDespite olfactory disorders being among the most common neurological complications of coronavirus disease 2019 (COVID-19), their pathogenesis has not been fully elucidated yet. Brain MR imaging is a consolidated method for evaluating olfactory system's morphological modification, but a few quantitative studies have been published so far. The aim of the study was to provide MRI evidence of olfactory system alterations in patients with COVID-19 and neurological symptoms, including olfactory dysfunction.

methods196 COVID-19 patients (median age: 53 years, 56% females) and 39 controls (median age 55 years, 49% females) were included in this cross-sectional observational study; 78 of the patients reported olfactory loss as the only neurological symptom. MRI processing was performed by ad-hoc semi-automatic processing procedures. Olfactory bulb (OB) volume was measured on T2-weighted MRI based on manual tracing and normalized to the brain volume. Olfactory tract (OT) median signal intensity was quantified on fluid attenuated inversion recovery (FLAIR) sequences, after preliminary intensity normalization.

resultsCOVID-19 patients showed significantly lower left, right and total OB volumes than controls (p < 0.05). Age-related OB atrophy was found in the control but not in the patient population. No significant difference was found between patients with olfactory disorders and other neurological symptoms. Several outliers with abnormally high OT FLAIR signal intensity were found in the patient group.

conclusionsBrain MRI findings demonstrated OB damage in COVID-19 patients with neurological complications. Future longitudinal studies are needed to clarify the transient or permanent nature of OB atrophy in COVID-19 pathology.

Indexed as

COVID-19Olfaction DisordersCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedOlfactory BulbSmellCOVID-19MRIOlfactory bulbsOlfactory dysfunctionOlfactory system

Identifiers

PMID36656356
PMCPMC9850323
OpenAlexW4317434390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.